Jiangsu Aidea Pharmaceutical Co Ltd
688488
Company Profile
Business description
Jiangsu Aidea Pharmaceutical Co Ltd produces and sells human-derived protein products, and also develops some generic drug businesses and distributes Abbott's HIV diagnostic equipment and reagents. The company focuses on development of new chemical entities of anti-tumor, anti-virus and cardiovascular areas, among which two NCE drugs for the treatment of Cancer and AIDS have been approved.
Contact
No. 2 Liuzhuang Road
Hanjiang District
Jiangsu Province
Yangzhou225008
CHNT: +86 51482090238
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
704
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,365.70 | 24.70 | 0.30% |
| CAC 40 | 7,593.87 | 38.00 | 0.50% |
| DAX 40 | 22,496.98 | 71.15 | 0.32% |
| Dow JONES (US) | 40,859.81 | 190.45 | 0.47% |
| FTSE 100 | 8,496.80 | 1.95 | 0.02% |
| HKSE | 22,119.41 | 111.30 | 0.51% |
| NASDAQ | 17,781.28 | 334.94 | 1.92% |
| Nikkei 225 | 36,452.30 | 406.92 | 1.13% |
| NZX 50 Index | 12,148.60 | 245.29 | 2.06% |
| S&P 500 | 5,623.95 | 54.89 | 0.99% |
| S&P/ASX 200 | 8,145.60 | 19.40 | 0.24% |
| SSE Composite Index | 3,279.03 | 7.62 | -0.23% |